NADH/NAD+ reductive stress in the liver emerges as the causal mechanism for features of the metabolic syndrome associated with hypomorphic GCKR, such as hepatic insulin resistance and increased triglyceride release (Goodman et al., 2020). The gene discussed is INS; the disease is metabolic syndrome.